Concord Biotech Ltd. share price target

Name: Latest research reports of Concord Biotech Ltd. authored by Hem Securities and published by - Trendlyne research reports.
Item: Concord Biotech Ltd.
Rating: 5
Author: Hem Securities

Latest broker research reports with buy, sell, hold recommendations along with forecast share price targets and upside. Browse thousands of reports and search by company or the broker.

Reco - This broker has downgraded this stock from it's previous report.
(eg. - Buy->Hold)

Target - Broker has maintained previous recommendation but reduced share price target.

Reco - This broker has upgraded this stock from it's previous report.
(eg. - Sell->Hold)

Target - Broker has maintained previous recommendation but increased share price target.

Click on any table column to sort reports by date, stock name, broker, price, target, upside or recommendation.

Date	Stock	Author	LTP	Target	Price at reco (Change since reco%)	Upside(%)	Type	Report	Discuss
02 Oct 2025	Concord Biotech	Consensus Share Price Target	1634.20	1861.67	-	13.92	buy	pdf Detailed Estimates
04 Aug 2023	Concord Biotech	Hem Securities	1634.20				IPO Subscribe	pdf post cache	Broker Report Concord Biotech Limited Hem Securities pdf Copy Link Share on Share on Share on Share on Alert
03 Aug 2023	Concord Biotech	HDFC Securities	1634.20				IPO Note	pdf post cache	Broker Report IPO Note- Concord Biotech Limited HDFC Securities Issue Snapshot: Issue Open: Aug 04 Aug 08, 2023 Price Band: Rs. 705 741 (Discount of Rs 70 for all eligible employees) *Issue Size: 20,925,652 eq sh (Entirely Offer for sale including Employee reservation of 10,000 eq sh) Reservation for: QIB upto 50% eq sh Non-Institutional atleast 15% eq sh ((including 1/3rd for applications between Rs.2 lakhs to Rs.10 lakhs)) Retail atleast 35% eq sh Face Value: Rs 1 Book value: Rs 123.31 (March 31, 2023) Bid size: - 20 equity shares and in multiples thereof 100% Book built Issue IPO Note- Concord Biotech Limited pdf Copy Link Share on Share on Share on Share on Alert
03 Aug 2023	Concord Biotech	Ashika Research	1634.20				IPO Note	pdf post cache	Broker Report Concord Biotech Ltd. IPO Note Ashika Research pdf Copy Link Share on Share on Share on Share on Alert

* Please note that subscribers can download a maximum of 300 reports a month and 70 reports everyday.

33.34% Fall from 52W High

Concord Biotech Ltd. share price target

Latest broker research reports with buy, sell, hold recommendations along with forecast share price targets and upside. Browse thousands of reports and search by company or the broker.

Concord Biotech Limited

IPO Note- Concord Biotech Limited

Concord Biotech Ltd. IPO Note

Advisor Screeners